Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera
Xu, Kun; An, Yaling; Liu, Xueyuan; Xie, Haitang; Li, Dedong; Yang, Ting; Duan, Minrun; Wang, Yuanzhuo; Zhao, Xin; Dai, Lianpai; Gao, George F. Share Save Share Save A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variantsHao, Tianjiao; Li, Yulei; Liu, Peipei; Wang, Xi; Xu, Ke; Lei, Wenwen; Li, Ying; Zhang, Rong; Li, Xiaoyan; Zhao, Xin; Xu, Kun; Lu, Xuancheng; Bi, Yuhai; Song, Hao; Wu, Guizhen; Zhu, Baoli; Gao, George F. Share Save Enhanced luminescence efficiency in GaN-based blue laser diodes by H plasma technologyWang, Lu; Xu, Kun; Yu, Guohao; Ren, Xiaoyu; Qin, Xulei; Zhang, Li; Chen, Tiwei; Zhang, Fan; Li, Fangzhi; Zhou, Jiaan; Xue, Bangda; Zeng, Zhongming; Liu, Jianping; Zhang, Baoshun Share Save Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastorisZhao, Tongxin; Liu, Sheng; Wang, Pengyan; Zhang, Yanfang; Kang, Xinrui; Pan, Xiaoqian; Li, Linjie; Li, Dedong; Gao, Ping; An, Yaling; Song, Hao; Liu, Kefang; Qi, Jianxun; Zhao, Xin; Dai, Lianpan; Liu, Peipei; Wang, Peiyi; Wu, Guizhen; Zhu, Taicheng; Xu, Kun; Li, Yin; Gao, George F. Share Save Share Save Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodiesHe, Qingwen; An, Yaling; Zhou, Xuemei; Xie, Haitang; Tao, Lifeng; Li, Dedong; Zheng, Anqi; Li, Linjie; Xu, Zepeng; Yu, Shufan; Wang, Ruyue; Hu, Hua; Liu, Kefang; Wang, Qihui; Dai, Lianpan; Xu, Kun; Gao, George F. Share Save Share Save Spatially resolved transcriptomics reveals distinct pulmonary immune responses during influenza virus and SARS-CoV-2 infectionsZhao, Min; Shao, Fei; Liu, Zhen; Ma, Jiangwen; Yu, Dou; Zhang, Hangjie; Dai, Lianpan; Xu, Kun; Zhao, Xin; Zheng, Mengli; Gao, George Fu; Wang, Shuo Share Save Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7Zhang, Yanfang; Kang, Xinrui; Liu, Sheng; Han, Pu; Lei, Wenwen; Xu, Ke; Xu, Zepeng; Gao, Zhengrong; Zhou, Xuemei; An, Yaling; Han, Yuxuan; Liu, Kefang; Zhao, Xin; Dai, Lianpan; Wang, Peiyi; Wu, Guizhen; Qi, Jianxun; Xu, Kun; Gao, George F. Share Save Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infectionDai, Lianpan; Duan, Huixin; Liu, Xueyuan; Zhou, Huan; Duan, Minrun; An, Yaling; Yuan, Linfeng; Zhao, Xin; Xu, Kun; Wu, Qiang; Gao, George F. Share Save Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccineGuo, Shuxin; Zheng, Yuxuan; Gao, Zhengrong; Duan, Minrun; Liu, Sheng; Du, Pan; Xu, XiaoYu; Xu, Kun; Zhao, Xin; Chai, Yan; Wang, Peiyi; Zhao, Qi; Gao, George F.; Dai, Lianpan Share Save Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBDLi, Yulei; Liu, Peipei; Hao, Tianjiao; Liu, Sheng; Wang, Xi; Xie, Yufeng; Xu, Ke; Lei, Wenwen; Zhang, Cheng; Han, Pu; Li, Ying; Jin, Xiyue; Huan, Yu; Lu, Yafei; Zhang, Rong; Li, Xiaoyan; Zhao, Xin; Xu, Kun; Liao, Pu; Lu, Xuancheng; Bi, Yuhai; Song, Hao; Wu, Guizhen; Zhu, Baoli; Gao, George F. Share Save Robust and protective immune responses induced by heterologous prime-boost vaccination with DNA-protein dimeric RBD vaccines for COVID-19An, Yaling; Zhao, Gan; Duan, Huixin; Zhang, Ning; Duan, Minrun; Xu, Senyu; Liu, Xueyuan; Han, Yuxuan; Zheng, Tianyi; Li, Xin; Hou, Jiawang; Zhang, Zhiyu; Bi, Yuhai; Zhao, Xin; Xu, Kun; Dai, Lianpan; Wang, Bin; Gao, George F. Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
